Literature DB >> 20008020

Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B.

Eduardo Fernandez-Rebollo1, Beatriz García-Cuartero, Intza Garin, Cristina Largo, Francisco Martínez, Concepcion Garcia-Lacalle, Luis Castaño, Murat Bastepe, Guiomar Pérez de Nanclares.   

Abstract

CONTEXT: Several endocrine diseases that share resistance to PTH are grouped under the term pseudohypoparathyroidism (PHP). Patients with PHP type Ia show additional hormone resistance, defective erythrocyte G(s)alpha activity, and dysmorphic features termed Albright's hereditary osteodystrophy (AHO). Patients with PHP-Ib show less diverse hormone resistance and normal G(s)alpha activity; AHO features are typically absent in PHP-Ib. Mutations affecting G(s)alpha coding exons of GNAS and epigenetic alterations in the same gene are associated with PHP-Ia and -Ib, respectively. The epigenetic GNAS changes in familial PHP-Ib are caused by microdeletions near or within GNAS but without involving G(s)alpha coding exons.
OBJECTIVE: We sought to identify the molecular defect in a patient who was diagnosed with PHP-Ia based on clinical presentation (hormone resistance and AHO) but displayed the molecular features typically associated with PHP-Ib (loss of methylation at exon A/B) without previously described genetic mutations.
METHODS: Microsatellite typing, comparative genome hybridization, and allelic dosage were performed for proband and her parents.
RESULTS: Comparative genome hybridization revealed a deletion of 30,431 bp extending from the intronic region between exons XL and A/B to intron 5. The same mutation was also demonstrated, by PCR, in the patient's mother, but polymorphism and allele dosage analyses indicated that she had this mutation in a mosaic manner.
CONCLUSION: We discovered a novel multiexonic GNAS deletion transmitted to our patient from her mother who is mosaic for this mutation. The deletion led to different phenotypic manifestations in the two generation and appeared, in the patient, as loss of GNAS imprinting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008020      PMCID: PMC2840867          DOI: 10.1210/jc.2009-1581

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

Review 1.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream.

Authors:  David G Ginzinger
Journal:  Exp Hematol       Date:  2002-06       Impact factor: 3.084

Review 2.  Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease.

Authors:  Christine J Shaw; James R Lupski
Journal:  Hum Mol Genet       Date:  2004-02-05       Impact factor: 6.150

3.  Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy.

Authors:  J L Patten; D R Johns; D Valle; C Eil; P A Gruppuso; G Steele; P M Smallwood; M A Levine
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

4.  Constitutional deletion of chromosome 20q in two patients affected with albright hereditary osteodystrophy.

Authors:  Micheala A Aldred; Salim Aftimos; Christine Hall; Katie S Waters; Rajesh V Thakker; Richard C Trembath; Louise Brueton
Journal:  Am J Med Genet       Date:  2002-11-22

5.  Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus.

Authors:  M Bastepe; J E Pincus; T Sugimoto; K Tojo; M Kanatani; Y Azuma; K Kruse; A L Rosenbloom; H Koshiyama; H Jüppner
Journal:  Hum Mol Genet       Date:  2001-06-01       Impact factor: 6.150

6.  Isolation and characterization of the human Gs alpha gene.

Authors:  T Kozasa; H Itoh; T Tsukamoto; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein.

Authors:  M A Levine; R W Downs; A M Moses; N A Breslau; S J Marx; R D Lasker; R E Rizzoli; G D Aurbach; A M Spiegel
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

8.  Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis.

Authors:  L S Weinstein; P V Gejman; E Friedman; T Kadowaki; R M Collins; E S Gershon; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.

Authors:  J Liu; D Litman; M J Rosenberg; S Yu; L G Biesecker; L S Weinstein
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

10.  Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.

Authors:  Murat Bastepe; Leopold F Fröhlich; Geoffrey N Hendy; Olafur S Indridason; Robert G Josse; Hiroyuki Koshiyama; Jarmo Körkkö; Jon M Nakamoto; Arlan L Rosenbloom; Arnold H Slyper; Toshitsugu Sugimoto; Agathocles Tsatsoulis; John D Crawford; Harald Jüppner
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  14 in total

1.  Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.

Authors:  Rieko Takatani; Angelo Molinaro; Giedre Grigelioniene; Olta Tafaj; Tomoyuki Watanabe; Monica Reyes; Amita Sharma; Vibha Singhal; F Lucy Raymond; Agnès Linglart; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-11-14       Impact factor: 6.741

2.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

Review 3.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

4.  Clinical utility gene card for: pseudohypoparathyroidism.

Authors:  Giovanna Mantovani; Agnes Linglart; Intza Garin; Caroline Silve; Francesca M Elli; Guiomar Perez de Nanclares
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

Review 5.  A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature.

Authors:  Alessandro Brancatella; Giovanna Mantovani; Francesca M Elli; Simona Borsari; Claudio Marcocci; Filomena Cetani
Journal:  Endocrine       Date:  2020-01-14       Impact factor: 3.633

6.  High frequency of paternal iso or heterodisomy at chromosome 20 associated with sporadic pseudohypoparathyroidism 1B.

Authors:  Cindy Colson; Matthieu Decamp; Nicolas Gruchy; Nadia Coudray; Céline Ballandonne; Claire Bracquemart; Arnaud Molin; Hervé Mittre; Rieko Takatani; Harald Jüppner; Marie-Laure Kottler; Nicolas Richard
Journal:  Bone       Date:  2019-03-21       Impact factor: 4.398

7.  Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib?

Authors:  Eduardo Fernández-Rebollo; Guiomar Pérez de Nanclares; Beatriz Lecumberri; Serap Turan; Emma Anda; Gustavo Pérez-Nanclares; Denice Feig; Serena Nik-Zainal; Murat Bastepe; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

Review 8.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

9.  European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study.

Authors:  Intza Garin; Giovanna Mantovani; Urko Aguirre; Anne Barlier; Bettina Brix; Francesca M Elli; Kathleen Freson; Virginie Grybek; Benedetta Izzi; Agnès Linglart; Guiomar Perez de Nanclares; Caroline Silve; Susanne Thiele; Ralf Werner
Journal:  Eur J Hum Genet       Date:  2014-07-09       Impact factor: 4.246

10.  Cutaneous nodules and a novel GNAS mutation in a Chinese boy with pseudohypoparathyroidism type Ia: A case report and review of literature.

Authors:  Yun-Ling Li; Ting Han; Fang Hong
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.